Toll-Like Receptor 9 Inactivation Alleviated Atherosclerotic Progression and Inhibited Macrophage Polarized to M1 Phenotype in ApoE-/- Mice

Disease Markers

Volumn 2015, Issue , 2015, Pages

  Ma, Chunmei ^a,b   Ouyang, Qiufang ^a,b   Huang, Ziyang ^a   Chen, Xiaoqing ^a   Lin, Ye ^a   Hu, Weiping ^a   Lin, Ling ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 7; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHOPROTEIN; TOLL LIKE RECEPTOR 9; APOLIPOPROTEIN E; IRF7 PROTEIN, MOUSE; TLR9 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL POLARITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL LINE; GENETICS; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; PATHOLOGY; PHENOTYPE;

MUS;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELL LINE; FEMALE; INTERFERON REGULATORY FACTOR-7; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; NF-KAPPA B; PHENOTYPE; TOLL-LIKE RECEPTOR 9;

EID: 84938276532     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2015/909572     Document Type: Article

References (20)

1. M. Peled and E. A. Fisher, "Dynamic aspects of macrophage polarization during atherosclerosis progression and regression, " Frontiers in Immunology, vol. 5, article 579, 2014.
2. O. Takeuchi and S. Akira, "Pattern recognition receptors and inflammation, " Cell, vol. 140, no. 6, pp. 805-820, 2010.
3. H. Hemmi, O. Takeuchi, T. Kawai et al., "A Toll-like receptor recognizes bacterial DNA, " Nature, vol. 408, no. 6813, pp. 740-745, 2000.
4. F. J. Barrat, T. Meeker, J. Gregorio et al., "Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors andmay promote systemic lupus erythematosus, " The Journal of Experimental Medicine, vol. 202, no. 8, pp. 1131-1139, 2005.
5. C. Parolini, M. Busnelli, G. S. Ganzetti et al., "Magnetic resonance imaging visualization of vulnerable atherosclerotic plaques at the brachiocephalic artery of apolipoprotein e knockoutmice by the blood-pool contrast agent B22956/1, "Molecular Imaging, vol. 13, no. 5, 2014.
6. C. Koulis, Y.-C. Chen, C. Hausding et al., "Protective role for toll-like receptor-9 in the development of atherosclerosis in apolipoprotein e-deficient mice, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 3, pp. 516-525, 2014.
7. J. M. Yang, Y. Wang, L. H. Qi et al., "Combinatorial interference of toll-like receptor 2 and 4 synergistically stabilizes atherosclerotic plaque in apolipoprotein E-knockout mice, " Journal of Cellular andMolecularMedicine, vol. 15, no. 3, pp. 602-611, 2011.
8. M. H. Moghadasian, B. M. McManus, L. B. Nguyen et al., "Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans, " The FASEB Journal, vol. 15, no. 14, pp. 2623-2630, 2001.
9. H. Williams, J. L. Johnson, K. G. S. Carson, and C. L. Jackson, "Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 5, pp. 788-792, 2002.
10. J. C. Karper, M. M. Ewing, K. L. L. Habets et al., "Blocking tolllike receptors 7 and 9 reduces postinterventional remodeling via reduced macrophage activation, foam cell formation, and migration, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 8, pp. e72-e80, 2012.
11. B. Razani, C. Feng, and C. F. Semenkovich, "p53 is required for chloroquine-induced atheroprotection but not insulin sensitization, " Journal of Lipid Research, vol. 51, no. 7, pp. 1738-1746, 2010.
12. K. S. Michelsen, M. H. Wong, P. K. Shah et al., "Lack of tolllike receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 29, pp. 10679-10684, 2004.
13. G. K. Hansson and A. Hermansson, "The immune system in atherosclerosis, " Nature Immunology, vol. 12, no. 3, pp. 204-212, 2011.
14. M. J. Butcher and E. V. Galkina, "Phenotypic and functional heterogeneity of macrophages and dendritic cell subsets in the healthy and atherosclerosis-prone aorta, " Frontiers in Physiology, vol. 3, article 44, 2012.
15. J.-S. Kim, D.-W. Park, H.-K. Lee, J.-R. Kim, and S.-H. Baek, "Early growth response-1 is involved in foam cell formation and is upregulated by the TLR9-MyD88-ERK1/2 pathway, " Biochemical and Biophysical Research Communications, vol. 390, no. 2, pp. 196-200, 2009.
16. J. Khallou-Laschet, A. Varthaman, G. Fornasa et al., "Macrophage plasticity in experimental atherosclerosis, " PLoS ONE, vol. 5, no. 1, Article IDe8852, 2010.
17. J.-Q. Gu, D.-F. Wang, X.-G. Yan et al., "A Toll-like receptor 9-mediated pathway stimulates perilipin 3 (TIP47) expression and induces lipid accumulation inmacrophages, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 299, no. 4, pp. E593-E600, 2010.
18. R. Sorrentino, S. Morello, S. Chen, E. Bonavita, and A. Pinto, "The activation of liver X receptors inhibits toll-like receptor-9-induced foam cell formation, " Journal of Cellular Physiology, vol. 223, no. 1, pp. 158-167, 2010.
19. H. Björkbacka, V. V. Kunjathoor, K. J. Moore et al., "Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways, " Nature Medicine, vol. 10, no. 4, pp. 416-421, 2004.
20. E. M. Hayes, A. Tsaousi, K. Di Gregoli et al., "Classical and alternative activation and metalloproteinase expression occurs in foamcell macrophages inmale and female ApoE null mice in the absence of T and B lymphocytes, " Frontiers in Immunology, vol. 5, article 537, 2014.